KALA - Kala Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5198.55M
Enterprise Value 3163.31M
Trailing P/E N/A
Forward P/E 1-3.29
PEG Ratio (5 yr expected) 1-0.06
Price/Sales (ttm)143.26
Price/Book (mrq)2.41
Enterprise Value/Revenue 3117.83
Enterprise Value/EBITDA 6-2.12

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,601.15%

Management Effectiveness

Return on Assets (ttm)-32.13%
Return on Equity (ttm)-99.40%

Income Statement

Revenue (ttm)1.39M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -77.19M
Net Income Avi to Common (ttm)-80.83M
Diluted EPS (ttm)-2.78
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)138.94M
Total Cash Per Share (mrq)4.1
Total Debt (mrq)101.67M
Total Debt/Equity (mrq)123.43
Current Ratio (mrq)10.30
Book Value Per Share (mrq)2.43

Cash Flow Statement

Operating Cash Flow (ttm)-72.58M
Levered Free Cash Flow (ttm)-44.54M

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-61.56%
S&P500 52-Week Change 34.96%
52 Week High 316.00
52 Week Low 34.03
50-Day Moving Average 37.24
200-Day Moving Average 36.85

Share Statistics

Avg Vol (3 month) 3201.92k
Avg Vol (10 day) 3188.28k
Shares Outstanding 533.88M
Float 20.31M
% Held by Insiders 14.25%
% Held by Institutions 181.36%
Shares Short (Apr 30, 2019) 41.72M
Short Ratio (Apr 30, 2019) 412.16
Short % of Float (Apr 30, 2019) 410.08%
Short % of Shares Outstanding (Apr 30, 2019) 45.09%
Shares Short (prior month Mar 29, 2019) 41.69M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A